SINOMAB BIO-B hits a new 52-week low, currently trading at $0.94, down approximately 2%Market Movers·Nov 20, 2026 at 02:32 AM03681-1.57%
SINOMAB BIO-B hits a 52-week low, currently trading at $0.95, down approximately 1%Market Movers·Nov 17, 2026 at 01:42 AM03681-1.57%
SinoMab Completes Disposal of Suzhou Property and FacilityTip Ranks·Nov 4, 2026 at 02:09 PM03681-1.57%
Hong Kong's junk-drawer stocks are all rebranding. Good luck with that.Global Report·Oct 21, 2026 at 10:51 AM03788-4.93%02621+12.50%
A Takeover, a Profit Warning, and Hong Kong's Forgotten Small CapsGlobal Report·Oct 13, 2026 at 10:52 AM02619-5.53%007690.00%
Hong Kong's Forgotten Stocks Find New Life Through Bailouts and BreakthroughsGlobal Report·Oct 13, 2026 at 09:24 AM01316-3.46%007690.00%
Special Dividends and Insider Buying Carry Hong Kong's Small-Cap TailGlobal Report·Oct 6, 2026 at 10:48 AM01515-2.11%02630-4.53%
Hong Kong Mid-Caps Offload Assets to Shore Up Liquidity as IPO Dreams FadeGlobal Report·Oct 6, 2026 at 09:17 AM01205-1.05%004930.00%
Regulatory Spotlight Hits Hong Kong's Silent Stock MarketGlobal Report·Sep 29, 2026 at 09:16 AM02362-5.32%01368-2.78%
The AI Pharma Pivot: How Biotech Is Redrawing the Hong Kong Market MapGlobal Report·Sep 23, 2026 at 10:48 AM02493-2.24%09936-6.35%
Hong Kong Tech Platforms Signal Structural Shift Amid Diverging FundamentalsGlobal Report·Sep 23, 2026 at 09:14 AM09936-6.35%03626-6.53%
SinoMab Clarifies Use of 2025 Share Proceeds and Share Award DetailsTip Ranks·Sep 18, 2026 at 11:12 AM03681-1.57%
Compute, Capital Convergence, and the Repricing of Hong Kong's Margin PlayersGlobal Report·Sep 16, 2026 at 11:32 AM03681-1.57%00520-3.88%